Chitosan-based nanoformulated (–)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis
Jean Christopher Chamcheu,1,2,* Imtiaz A Siddiqui,1,* Vaqar M Adhami,1,* Stephane Esnault,3 Dhruba J Bharali,4 Abiola S Babatunde,1,5 Stephanie Adame,1 Randall J Massey,6 Gary S Wood,1 B Jack Longley,1 Shaker A Mousa,4 Hasan Mukhtar11Department of Dermatology, School of Medicine and Public...
Saved in:
Main Authors: | Chamcheu JC, Siddiqui IA, Adhami VM, Esnault S, Bharali DJ, Babatunde AS, Adame S, Massey RJ, Wood GS, Longley BJ, Mousa SA, Mukhtar H |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/53eec2a944e449b39137010fdacb57e5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conjugation Of EGCG And Chitosan NPs As A Novel Nano-Drug Delivery System
by: Safer AM, et al.
Published: (2019) -
Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant
by: Yucheol Cheong, et al.
Published: (2021) -
In vitro study on anti-inflammatory effects of epigallocatechin-3-gallate-loaded nano- and microscale particles
by: Wu YR, et al.
Published: (2017) -
Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice
by: Gao,Jintao, et al.
Published: (2020) -
Psoriasis
by: MOLL LEE,NORMAN
Published: (1947)